Moderna (MRNA) Exchange Rate Effect (2024 - 2026)

Moderna (MRNA) has 3 years of Exchange Rate Effect data on file, last reported at $1.0 million in Q1 2026.

• Exchange Rate Effect for Q1 2026 came in at $1.0 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $3.0 million (changed N/A YoY), and the FY2025 annual result was $2.0 million, changed N/A from the prior year.
• Exchange Rate Effect held at $1.0 million in Q1 2026 per MRNA's latest filing, from $1.0 million in the prior quarter.
• Over five years, Exchange Rate Effect peaked at $1.0 million in Q3 2024 and troughed at -$1.0 million in Q4 2024.
• A 3-year average of $600000.0 and a median of $1.0 million in 2024 frame the typical range for Exchange Rate Effect.
• On a YoY basis, Exchange Rate Effect climbed as much as 0.0% in 2025 and fell as far as 0.0% in 2025.
• A 3-year view of Exchange Rate Effect shows it stood at -$1.0 million in 2024, then jumped by 200.0% to $1.0 million in 2025, then changed by 0.0% to $1.0 million in 2026.
• Business Quant data shows MRNA's Exchange Rate Effect at $1.0 million in Q1 2026, $1.0 million in Q3 2025, and $1.0 million in Q2 2025.